Suppr超能文献

转录因子E4F1协调CHK1依赖性检查点和线粒体功能。

The transcription factor E4F1 coordinates CHK1-dependent checkpoint and mitochondrial functions.

作者信息

Rodier Geneviève, Kirsh Olivier, Baraibar Martín, Houlès Thibault, Lacroix Matthieu, Delpech Hélène, Hatchi Elodie, Arnould Stéphanie, Severac Dany, Dubois Emeric, Caramel Julie, Julien Eric, Friguet Bertrand, Le Cam Laurent, Sardet Claude

机构信息

Equipe labellisée Ligue Contre le Cancer, Institut de Génétique Moléculaire de Montpellier, UMR5535, Centre National de la Recherche Scientifique (CNRS), 34293 Montpellier, France; Institut de Recherche en Cancérologie de Montpellier (IRCM), 34298 Montpellier, France; Institut National de la Santé et de la Recherche Médicale (INSERM), U1194, 34298 Montpellier, France; Université de Montpellier, 34090 Montpellier, France; Institut régional du Cancer de Montpellier, 34298 Montpellier, France.

Equipe labellisée Ligue Contre le Cancer, Institut de Génétique Moléculaire de Montpellier, UMR5535, Centre National de la Recherche Scientifique (CNRS), 34293 Montpellier, France; Université de Montpellier, 34090 Montpellier, France.

出版信息

Cell Rep. 2015 Apr 14;11(2):220-33. doi: 10.1016/j.celrep.2015.03.024. Epub 2015 Apr 2.

Abstract

Recent data support the notion that a group of key transcriptional regulators involved in tumorigenesis, including MYC, p53, E2F1, and BMI1, share an intriguing capacity to simultaneously regulate metabolism and cell cycle. Here, we show that another factor, the multifunctional protein E4F1, directly controls genes involved in mitochondria functions and cell-cycle checkpoints, including Chek1, a major component of the DNA damage response. Coordination of these cellular functions by E4F1 appears essential for the survival of p53-deficient transformed cells. Acute inactivation of E4F1 in these cells results in CHK1-dependent checkpoint deficiency and multiple mitochondrial dysfunctions that lead to increased ROS production, energy stress, and inhibition of de novo pyrimidine synthesis. This deadly cocktail leads to the accumulation of uncompensated oxidative damage to proteins and extensive DNA damage, ending in cell death. This supports the rationale of therapeutic strategies simultaneously targeting mitochondria and CHK1 for selective killing of p53-deficient cancer cells.

摘要

最近的数据支持这样一种观点,即一组参与肿瘤发生的关键转录调节因子,包括MYC、p53、E2F1和BMI1,具有同时调节代谢和细胞周期的有趣能力。在这里,我们表明另一个因子,多功能蛋白E4F1,直接控制参与线粒体功能和细胞周期检查点的基因,包括Chek1,它是DNA损伤反应的主要成分。E4F1对这些细胞功能的协调似乎对p53缺陷型转化细胞的存活至关重要。在这些细胞中急性失活E4F1会导致CHK1依赖的检查点缺陷和多种线粒体功能障碍,从而导致活性氧产生增加、能量应激以及从头嘧啶合成受到抑制。这种致命的组合会导致蛋白质未得到补偿的氧化损伤积累和广泛的DNA损伤,最终导致细胞死亡。这支持了同时靶向线粒体和CHK1以选择性杀死p53缺陷型癌细胞的治疗策略的基本原理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验